PSYVAULT Trademark

Trademark Overview


On Tuesday, December 29, 2020, a trademark application was filed for PSYVAULT with the United States Patent and Trademark Office. The USPTO has given the PSYVAULT trademark a serial number of 90426844. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by CB Therapeutics, INC.. The PSYVAULT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Online retail store services featuring pharmaceutically active compounds for treating medical conditions, including psychological and mental health disorders, neurological disorders, appetite disorders, sleep disorders, obsessive-compulsive disorder, depression, and addiction, alcohol dependence, stimulant dependence, cocaine addiction, tobacco addiction, nicotine addiction, opioid addiction, cannabis dependence anxiety disorders such as, post-traumatic stress disorder, generalized anxiety disorder, obsessive-compulsive disorder, advanced-state cancer-related anxiety, psychological distress associated with existential crisis of terminal disease, adjustment disorder with anxiety, cancer-related depression, treatment-resistant depression, major depressive disorder, severe existential depression, suicidality, cluster headaches, chronic pain, intractable phantom pain and demoralization via the internet; promoting the goods of others, namely, providing coupons, rebates and vouchers for phar...
psyvault

General Information


Serial Number90426844
Word MarkPSYVAULT
Filing DateTuesday, December 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesOnline retail store services featuring pharmaceutically active compounds for treating medical conditions, including psychological and mental health disorders, neurological disorders, appetite disorders, sleep disorders, obsessive-compulsive disorder, depression, and addiction, alcohol dependence, stimulant dependence, cocaine addiction, tobacco addiction, nicotine addiction, opioid addiction, cannabis dependence anxiety disorders such as, post-traumatic stress disorder, generalized anxiety disorder, obsessive-compulsive disorder, advanced-state cancer-related anxiety, psychological distress associated with existential crisis of terminal disease, adjustment disorder with anxiety, cancer-related depression, treatment-resistant depression, major depressive disorder, severe existential depression, suicidality, cluster headaches, chronic pain, intractable phantom pain and demoralization via the internet; promoting the goods of others, namely, providing coupons, rebates and vouchers for pharmaceutically active compounds for treating Medical conditions, including psychological and mental health disorders, neurological disorders, appetite disorders, sleep disorders, depression, and addiction, alcohol dependence, stimulant dependence, cocaine addiction, tobacco addiction, nicotine addiction, opioid addiction, cannabis dependence anxiety disorders such as, posttraumatic stress disorder, generalized anxiety disorder, obsessive-compulsive disorder, advanced-state cancer-related anxiety, psychological distress associated with existential crisis of terminal disease, adjustment disorder with anxiety, cancer-related depression, treatment-resistant depression, major depressive disorder, severe existential depression, suicidality, cluster headaches, chronic pain, intractable phantom pain and demoralization via the internet; providing a searchable online advertising web site and informational guide featuring the goods of other vendors via the internet, in the field of pharmaceutically active compounds for treating medical conditions, including psychological and mental health disorders, neurological disorders, appetite disorders, sleep disorders, depression, and addiction, alcohol dependence, stimulant dependence, cocaine addiction, tobacco addiction, nicotine addiction, opioid addiction, cannabis dependence anxiety disorders such as, post-traumatic stress disorder, generalized anxiety disorder, obsessive-compulsive disorder, advanced-state cancer-related anxiety, psychological distress associated with existential crisis of terminal disease, adjustment disorder with anxiety, cancer-related depression, treatment-resistant depression, major depressive disorder, severe existential depression, suicidality, cluster headaches, chronic pain, intractable phantom pain and demoralization

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, March 22, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCB Therapeutics, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Party NameCB Therapeutics, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Trademark Events


Event DateEvent Description
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 15, 2023SOU EXTENSION 1 GRANTED
Monday, May 15, 2023SOU EXTENSION 1 FILED
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 8, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 8, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 8, 2022FINAL REFUSAL E-MAILED
Tuesday, February 8, 2022FINAL REFUSAL WRITTEN
Tuesday, January 18, 2022ASSIGNED TO EXAMINER
Tuesday, December 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 26, 2021NON-FINAL ACTION E-MAILED
Saturday, June 26, 2021NON-FINAL ACTION WRITTEN
Saturday, June 26, 2021ASSIGNED TO EXAMINER
Monday, March 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 1, 2021NEW APPLICATION ENTERED